Daehan Nupharm Co.,Ltd. (KOSDAQ:054670)
South Korea · Delayed Price · Currency is KRW 5,850.00
-130.00 (-2.17%)
At close: Jun 1, 2026
Daehan Nupharm Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 15,677 | 15,258 | 15,468 | 12,542 | 24,317 | 15,694 |
Depreciation & Amortization | 4,380 | 4,302 | 4,098 | 3,481 | 3,228 | 3,330 |
Loss (Gain) From Sale of Assets | 290.22 | 289.84 | 0.53 | 0.53 | -9.51 | 0.36 |
Loss (Gain) From Sale of Investments | -5,992 | -4,511 | -1,281 | -2,547 | 1,608 | 290.39 |
Loss (Gain) on Equity Investments | 133.99 | 253.77 | 466.76 | 142.53 | 26.5 | - |
Provision & Write-off of Bad Debts | -628.99 | -322.05 | 2,065 | -19.75 | -762.19 | 124.23 |
Other Operating Activities | 385.89 | -352.57 | 4,241 | 9,018 | 131.06 | 696.14 |
Change in Accounts Receivable | 2,094 | 3,015 | -977.64 | -2,190 | -6,059 | 166.57 |
Change in Inventory | -4,999 | -7,219 | -6,858 | -4,136 | -11,599 | -4,803 |
Change in Accounts Payable | -1,839 | 2,399 | 2,236 | -1,417 | 3,446 | 3,346 |
Change in Income Taxes | - | - | - | 591.5 | -3,265 | - |
Change in Other Net Operating Assets | -7,547 | -8,052 | -512.12 | -2,899 | 3,191 | -2,260 |
Operating Cash Flow | 1,956 | 5,061 | 18,947 | 12,567 | 14,253 | 16,583 |
Operating Cash Flow Growth | -81.77% | -73.29% | 50.77% | -11.83% | -14.05% | 22.42% |
Capital Expenditures | -43,536 | -50,236 | -33,029 | -9,737 | -3,432 | -10,625 |
Sale of Property, Plant & Equipment | 5.8 | - | - | 0.91 | 21.55 | 0.59 |
Sale (Purchase) of Intangibles | -654.89 | -645.39 | -687.67 | -331.24 | -13.51 | -128.68 |
Sale (Purchase) of Real Estate | 0 | -187.73 | -568.08 | - | -82.74 | -269.21 |
Investment in Securities | -725.75 | -731.04 | 4,562 | -2,036 | -3,224 | -3,127 |
Other Investing Activities | - | -0 | -0 | -0 | 144.28 | 474.29 |
Investing Cash Flow | -45,261 | -52,151 | -29,123 | -12,303 | -6,926 | -13,925 |
Short-Term Debt Issued | - | 18,781 | 18,927 | 23,123 | 17,188 | 24,442 |
Long-Term Debt Issued | - | 35,256 | 18,831 | - | - | 15,800 |
Total Debt Issued | 112,575 | 54,037 | 37,758 | 23,123 | 17,188 | 40,242 |
Short-Term Debt Repaid | - | -14,518 | -15,119 | -19,692 | -12,031 | -35,152 |
Long-Term Debt Repaid | - | -751.05 | -725.77 | -4,310 | -5,418 | -7,834 |
Total Debt Repaid | -75,545 | -15,269 | -15,845 | -24,001 | -17,449 | -42,987 |
Net Debt Issued (Repaid) | 37,030 | 38,768 | 21,913 | -878.16 | -260.42 | -2,745 |
Dividends Paid | -1,404 | -1,404 | -1,404 | -1,404 | -1,123 | - |
Other Financing Activities | -0 | -0 | - | 50 | 0 | 20 |
Financing Cash Flow | 35,627 | 37,365 | 20,510 | -2,232 | -1,383 | -2,725 |
Foreign Exchange Rate Adjustments | 49.5 | -34.63 | 190.73 | 13.5 | -90.95 | 0.12 |
Miscellaneous Cash Flow Adjustments | 0 | 0 | - | - | -0 | 0 |
Net Cash Flow | -7,629 | -9,760 | 10,524 | -1,954 | 5,853 | -66.3 |
Free Cash Flow | -41,580 | -45,175 | -14,083 | 2,830 | 10,822 | 5,958 |
Free Cash Flow Growth | - | - | - | -73.85% | 81.63% | 45.96% |
Free Cash Flow Margin | -20.24% | -22.32% | -6.97% | 1.39% | 5.47% | 3.58% |
Free Cash Flow Per Share | - | -3218.69 | -1003.40 | 201.62 | 771.04 | 424.51 |
Cash Interest Paid | 3,481 | 3,187 | 2,192 | 1,770 | 1,235 | 886.76 |
Cash Income Tax Paid | 3,232 | 4,169 | 2,945 | 2,747 | 4,185 | 9,249 |
Levered Free Cash Flow | -42,638 | -46,138 | -16,021 | 4,021 | -3,011 | 5,014 |
Unlevered Free Cash Flow | -41,563 | -45,094 | -14,921 | 5,122 | -2,227 | 5,582 |
Change in Working Capital | -12,290 | -9,856 | -6,112 | -10,050 | -14,286 | -3,551 |